 |
IDEA Collider: Innovation & Asymmetric Learning in PharmaAuthor: IDEA Pharma, SAI MedPartners
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. The podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare. Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking. Questions We Explore * What is asymmetric learning, and how does it fuel pharma innovation? * Why do some organizations outpace othersand what can we learn from them? * How can we overcome barriers to meaningful progress in healthcare? * Whats broken in traditional innovation modelsand how do we fix it? Listen and subscribe on all major platforms. Language: en Genres: Business, Life Sciences, Marketing, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
AI-Driven Pharma Market Research: Synthetic Users - with Kwame Ferreira & Rebecca Gould.
Episode 20
Wednesday, 7 October, 2026
Welcome back to the IDEA Collider podcast. In this episode, host Rick Ritacco sits down with Kwame Ferreira, Founder of Synthetic Users, and Rebecca Gould, President, Strategic Consulting & Analytics Business Unit at SAI. Together, they explore how artificial intelligence and synthetic behavioral modeling are transforming pharmaceutical market research and insight generation. For decades, market research operated under a strict constraint: you could choose two between speed, price, and quality, but never all three. Rebecca and Kwame discuss how synthetic user technology breaks this triangle, allowing biopharma teams to generate high-quality qualitative insights rapidly and cost-effectively. Kwame breaks down the architecture behind synthetic users—defining them as an abstraction of brain architecture that replicates human emotional responses, cognitive biases, and system 1 behaviors rather than striving for super intelligence. Rebecca shares real-world case studies in rare diseases, competitive simulation workshops, and creative concept testing where synthetic personas achieved over 90% parity with live human respondents. Tune in to discover how synthetic research is empowering healthcare leaders to make faster, higher-confidence decisions across the thousands of choices required to bring a medicine to market. Keep up with the GuestsRebecca Gould's LinkedIn: https://www.linkedin.com/in/rebecca-gould-b30b73/Kwame Ferreira's LinkedIn: https://www.linkedin.com/in/kwame-ferreira-1b06a31/ Keep up with Rick Ritacco:LinkedIn: https://www.linkedin.com/in/rritacco/ Follow IDEA Pharma On;Website: https://www.ideapharma.com/ Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/
